NRx Pharma因FDA完成氯胺酮ANDA审查而上涨 (NRXP:NASDAQ)
· seekingalpha.com
NRx Pharmaceuticals (NRXP) 股价大涨，此前 FDA 完成了该公司无防腐剂氯胺酮的初步审查。在此阅读更多内容。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...